Immuron (IMRN) Profit After Tax (2016 - 2024)
Immuron (IMRN) recorded quarterly Profit After Tax of -$1.6 million in Q4 2024, up 21.49% quarter-over-quarter from -$2.1 million in Q4 2023, and up 21.49% on a YoY basis from -$1.3 million in Q1 2024.
Immuron (IMRN) Profit After Tax (2016 - 2024) Analysis & Trends
Immuron's Profit After Tax history runs 9 years deep, the most recent figure standing at -$1.6 million for Q4 2024.
- In Q4 2024, Profit After Tax rose 21.49% year-over-year to -$1.6 million; the TTM figure through Dec 2024 stood at -$8.2 million (up 4.83% YoY), while the FY2025 annual figure was -$3.4 million, up 25.69% from the prior year.
- Profit After Tax was -$1.6 million for Q4 2024 at Immuron, up from -$2.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$13260.2 in Q4 2021 to a low of -$6.5 million in Q2 2021.
- Historically, Profit After Tax has averaged -$2.1 million across 5 years, with a median of -$2.0 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Profit After Tax surged 76.89% in 2021, then tumbled 14819.74% in 2022.
- A 5-year view of Profit After Tax shows it stood at -$57387.7 in 2020, then soared by 76.89% to -$13260.2 in 2021, then sank by 14819.74% to -$2.0 million in 2022, then decreased by 4.79% to -$2.1 million in 2023, then advanced by 21.49% to -$1.6 million in 2024.
- The last three Profit After Tax figures came in at -$1.6 million (Q4 2024), -$2.1 million (Q4 2023), and -$2.5 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.63 Mn |
| Dec 31, 2023 | -2.07 Mn |
| Jun 30, 2023 | -2.53 Mn |
| Dec 31, 2022 | -1.98 Mn |
| Jun 30, 2022 | -2.04 Mn |
| Dec 31, 2021 | -13,260.17 |
| Jun 30, 2021 | -6.46 Mn |
| Dec 31, 2020 | -57,387.72 |
| Jun 30, 2020 | -1.92 Mn |
| Dec 31, 2019 | -15,212.27 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | -1.47 Mn |
| Sep 28, 2017 | -4.76 Mn |
| Dec 31, 2016 | -2.57 Mn |
| Jun 30, 2016 | -3.28 Mn |